DNA Insulin Drops 2019
Active substance: CHROMIUM, LYCOPODIUM CLAVATUM SPORE, VANADIUM, PANCRELIPASE AMYLASE, INSULIN GLULISINE, PHOSPHORIC ACID, URANYL NITRATE HEXAHYDRATE, RADIUM BROMIDE
LIQUID · CHROMIUM 6 [hp_X]/59mL, LYCOPODIUM CLAVATUM SPORE 6 [hp_X]/59mL, VANADIUM 6 [hp_X]/59mL, PANCRELIPASE AMYLASE 6 [hp_X]/59mL, INSULIN GLULISINE 12 [hp_X]/59mL, PHOSPHORIC ACID 30 [hp_X]/59mL, URANYL NITRATE HEXAHYDRATE 30 [hp_X]/59mL, RADIUM BROMIDE 60 [hp_X]/59mL
United StatesActive
Marketing holder: Professional Complementary Health Formulas
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- CHROMIUM · 6 [hp_X]/59mL
- LYCOPODIUM CLAVATUM SPORE · 6 [hp_X]/59mL
- VANADIUM · 6 [hp_X]/59mL
- PANCRELIPASE AMYLASE · 6 [hp_X]/59mL
- INSULIN GLULISINE · 12 [hp_X]/59mL
- PHOSPHORIC ACID · 30 [hp_X]/59mL
- URANYL NITRATE HEXAHYDRATE · 30 [hp_X]/59mL
- RADIUM BROMIDE · 60 [hp_X]/59mL
Registration
- Registration number
- 63083-2019
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 63083-2019 · Verified 2026-10-09 · open in source